Holen Sie sich die Stockscreener-App
2.50
5.66%
-0.15
Handel nachbörslich:
2.52
0.02
+0.80%
Processa Pharmaceuticals Inc Aktie (PCSA) Neueste Nachrichten
Processa Pharmaceuticals Inc. (PCSA) Q4 2025 Earnings: EPS Misses Estimates as Biotech Focuses on Clinical PipelineMarket Buzz Alerts - Newser
Processa Pharmaceuticals Inc. (PCSA) Q4 2025 Earnings: Wider-Than-Expected Loss as Clinical Pipeline ProgressesViral Momentum Trades - Newser
Processa Pharmaceuticals CAO Wendy Guy buys $4,701 in stock - Investing.com India
Processa Pharmaceuticals president David Young buys $4,588 in shares - Investing.com India
Processa Pharmaceuticals CEO George Ng buys $5,473 in stock By Investing.com - Investing.com South Africa
Sian Bigora, Processa CDO, buys $5,341 in stock - Investing.com UK
Processa Pharmaceuticals CAO Wendy Guy buys $4,701 in stock By Investing.com - Investing.com Canada
Processa Pharmaceuticals president David Young buys $4,588 in shares By Investing.com - Investing.com Australia
Processa Pharmaceuticals CEO George Ng buys $5,473 in stock - Investing.com
Processa (NASDAQ: PCSA) strategy chief buys 1,369 shares in open market - Stock Titan
Processa (PCSA) CEO adds 1,843 shares and corrects prior Form 4 - Stock Titan
Processa (PCSA) R&D head buys 1,545 shares at $2.97 in open market - Stock Titan
Processa Pharmaceuticals (NASDAQ: PCSA) CAO purchases 1,583 shares and corrects prior Form 4 - Stock Titan
Processa Pharmaceuticals (PCSA) CFO adds 1,984 shares in Form 4 buy - Stock Titan
Processa (NASDAQ: PCSA) CEO George Ng buys 1,843 shares in open market - Stock Titan
Processa Pharmaceuticals (PCSA) CDO buys 1,971 shares in open-market trade - Stock Titan
What Processa Pharmaceuticals PCSA is doing that separates it from the herd Modest Gains 20260507Viral Momentum Stocks - Newser
Processa Pharmaceuticals (PCSA) holder CVI reports 200,000-share stake, 7.0% - Stock Titan
TradingKey - TradingKey
The valuation case for Processa Pharmaceuticals (PCSA) that is hard to ignore (+4.36%) 2026-05-08Viral Momentum Trades - Newser
Processa Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
[10-Q] Processa Pharmaceuticals, Inc. Quarterly Earnings Report - Stock Titan
Processa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Guy Wendy - Moomoo
Processa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Ng George K - Moomoo
Processa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Lin Patrick - Moomoo
2025 Executive Compensation, Ownership, and Governance Overview for Heatwurx, Inc. (Now Based in Vero Beach, FL) - Minichart
Processa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer SKIBSTED RUSSELL - Moomoo
Insider Buying: Russell Skibsted Acquires Additional Shares of P - GuruFocus
Processa Pharmaceuticals CFO Skibsted buys $5,891 in stock By Investing.com - Investing.com Australia
Processa Pharmaceuticals CFO Skibsted buys $5,891 in stock - Investing.com
Processa Pharma strategy chief Lin buys $4,064 in stock By Investing.com - Investing.com India
Processa Pharma strategy chief Lin buys $4,064 in stock - Investing.com
Processa (PCSA) CAO Wendy Guy buys 1,748 shares in open-market trade - Stock Titan
Processa Pharmaceuticals president David Young buys $4,589 in shares By Investing.com - Investing.com Australia
Processa Pharmaceuticals CEO George Ng buys $5,471 in company stock By Investing.com - Investing.com India
Processa Pharmaceuticals president David Young buys $4,589 in shares - Investing.com
Processa Pharmaceuticals CEO George Ng buys $5,471 in company stock - Investing.com
David Young of Processa (NASDAQ: PCSA) buys 1,706 shares at $2.69 - Stock Titan
Processa Pharmaceuticals (PCSA) CFO adds 2,190 shares in open-market buy - Stock Titan
Processa (NASDAQ: PCSA) CEO George Ng buys 2,034 shares in open-market trade - Stock Titan
Processa (PCSA) strategy chief buys 1,511 shares at $2.69 - Stock Titan
Processa (NASDAQ: PCSA) CDO adds 1,986 shares in open-market buy - Stock Titan
Processa Pharmaceuticals | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Ng George Kmoomoo - Moomoo
PCSA (Processa Pharmaceuticals) shares gain nearly 2 percent despite wider than expected Q4 2025 per share loss.Preliminary Results - Newser
0.98%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):